Synthesis and Preclinical Evaluation of the Fibrin-Binding Cyclic Peptide <sup>18</sup>F-iCREKA: Comparison with Its Contrasted Linear Peptide

<div>(a) Micro-PET imaging (60 min after tail vein injection) of <sup>18</sup>F-NOTA-LP and <sup>18</sup>F-NOTA-iCREKA in U87MG xenograft-bearing mice and Caov3 xenograft-bearing mice; (b) dynamic analyses of <sup>18</sup>F-NOTA-LP and <sup>18</sup>F-NOTA-iCREKA in U87MG xenograft-bearing mice.</div>

Contrast Media & Molecular Imaging

fig5

Figure 5

Figure 5: Synthesis and Preclinical Evaluation of the Fibrin-Binding Cyclic Peptide <sup>18</sup>F-iCREKA: Comparison with Its Contrasted Linear Peptide 

Contrast Media & Molecular Imaging

Synthesis and Preclinical Evaluation of the Fibrin-Binding Cyclic Peptide 18F-iCREKA: Comparison with Its Contrasted Linear Peptide

Figure 5

Synthesis and Preclinical Evaluation of the Fibrin-Binding Cyclic Peptide ¹⁸F-iCREKA: Comparison with Its Contrasted Linear Peptide